Navigation Links
Pharmos Corporation Reports 2008 First Quarter Results
Date:5/8/2008

mune disorders. The Company's lead product, dextofisopam, is being studied in a Phase 2b clinical trial in patients with IBS. Dextofisopam has completed a Phase 2a IBS study in which it demonstrated a statistically significant effect compared to placebo on the primary efficacy endpoint of adequate relief (n=141, p=0.033) and was very well tolerated. A second program in Phase 2a involves a clinical trial of our NanoEmulsion cream drug delivery system to deliver the NSAID diclofenac topically in patients suffering from osteoarthritic knee pain. The Company's core proprietary technology platform focuses on discovery and development of synthetic cannabinoid compounds, especially CB2 receptor-selective (CB2-selective) agonists. PRS-639,058, the leading CB2-selective agonist, has demonstrated promising preclinical data in neuropathic pain. Various other CB2-selective compounds from Pharmos' pipeline are in preclinical studies targeting pain, multiple sclerosis, rheumatoid arthritis, inflammatory bowel disease and other disorders.

Safe Harbor Statement

Statements made in this press release related to the business outlook and future financial performance of Pharmos, to the prospective market penetration of its drug products, to the development and commercialization of its pipeline products and to its expectations in connection with any future event, condition, performance or other matter, are forward-looking and are made pursuant to the safe harbor provisions of the Securities Litigation Reform Act of 1995. Such statements involve risks and uncertainties that may cause results to differ materially from those set forth in these statements. Additional economic, competitive, governmental, technological, marketing and other factors identified in Pharmos' filings with the Securities and Exchange Commission could affect such results.

(Tables attached)

PHARMOS CORPORATION

(Unaudited)

Consolidated Statements
'/>"/>

SOURCE Pharmos Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Pharmos Issues Letter to Shareholders
2. Pharmos Corporation Reports 2007 Third Quarter Results
3. Pharmos Corporation to Present at the 2007 RBC Capital Markets Healthcare Conference
4. Pharmos Corporation Announces President & COO Alan L. Rubino to Leave Company
5. Pharmos Corporation Announces Board and Management Changes
6. Pharmos Corporation Completes Initial Closing of Private Placement
7. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
8. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
9. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
10. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
11. BioElectronics Corporation Announces Singapore and Malaysia Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)...  An entire month is dedicated to one of ... disease (CMT) – a debilitating neuromuscular disease affecting the ... weakness, and foot and hand deformities. CMT affects 1 ... is a progressive disease, and over time patients lose ... such as leg braces, wheelchairs and scooters to get ...
(Date:9/19/2014)... Charlotte, NC (PRWEB) September 19, 2014 ... Certified Biobased Product Label for its Organic Cotton ... the product’s amount of renewable biobased ingredients meets or ... or intermediate materials composed in whole or in significant ... “This logo/label will allow our Organic cotton to be ...
(Date:9/18/2014)... 2014 Bipartisan passage this week by ... to stimulate development and commercialization of new technologies and ... leaders of SPIE, the international society for optics ... and Innovation (RAMI) Act, now moves to the full ... they are optimistic that it will win passage there ...
(Date:9/18/2014)...  Health Enhancement Products, Inc. (OTCQB: HEPI), a ... and metabolic processes, is pleased to announce the addition of ... Nola E. Masterson , a California ... September 17, 2014. "We,re very pleased and ... states Andrew Dahl , President and CEO. "She joins ...
Breaking Biology Technology:September is Charcot-Marie-Tooth (CMT) Awareness Month - Scheduled events, activities and important partnerships announced throughout the month! 2Barnhardt Manufacturing Company Earns USDA Certified Biobased Product Certification and Label for Organic Cotton 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 2House passage of high-tech manufacturing bill is move toward stronger economy, say SPIE leaders 3Health Enhancement Announces New Board Member In Advance Of Annual Shareholder Meeting 2
... BRAY, Ireland, December 20, 2011 Osteologix Holdings, ... 0.06 per sharepayable to shareholders of record on December 19, ... payment date is being delayed to allow time for certain ... the Company by shareholders prior to dividend payment. ...
... The new measurements, by UCLA physics professor Giovanni Zocchi and ... times higher in resolution than previous mechanical measurements, a nanotechnology ... a solid nor a liquid. "Proteins are the molecular ... said. "We have found that sometimes they behave as a ...
... tasks -- may have applications in areas outside of ... and his collaborators. Working at the interface of ... Pitt,s Department of Physics and Astronomy in the Kenneth ... colleagues report their findings in a paper published online ...
Cached Biology Technology:Osteologix Announces Dividend 2Osteologix Announces Dividend 3UCLA physicists report nanotechnology feat with proteins 2Quantum computing has applications in magnetic imaging, say Pitt researchers 2
(Date:9/18/2014)... the International Space Station ever starts a "frequent flyers" ... status. Recently the orbiting laboratory has hosted increasing numbers ... returned from the space station in April, and another ... third experiment is planned to launch in December. , ... around the world-- and in space. Model organisms can ...
(Date:9/18/2014)... genetic information is stored in DNA, tiny strands of ... our bodies. To express this genetic data, our DNA ... instructions into proteins that perform tasks in our cells. ... type of RNA molecule. Unlike all other known RNAs, ... Although circRNA molecules are abundant, little has been known ...
(Date:9/18/2014)... to be cheerful, happy-go-lucky characters, so you might expect ... , In fact some dogs are distinctly more ... shows. , "This research is exciting because it ... and non-invasively. It offers researchers and dog owners an ... changes," said Dr Melissa Starling, from the Faculty of ...
Breaking Biology News(10 mins):Buzzing with activity: Fruit flies orbit Earth for science 2Buzzing with activity: Fruit flies orbit Earth for science 3Buzzing with activity: Fruit flies orbit Earth for science 4Scientists find how mysterious 'circular RNA' is formed, claim muscular dystrophy link 2Dogs can be pessimists too 2Dogs can be pessimists too 3
... or a missed ball can put a crimp in an ... but the processes occurring under the skin remain full of ... blood cells, mobilize to protect injured body tissue from infection. ... othersare attracted to damaged tissue. The response begins when ...
... should abandon the concept of carbon emissions trading in ... to genuine reductions in the amount of carbon dioxide ... mechanism for reducing climate change. Details of the carbon ... Environmental Review . Carbon emissions trading was to ...
... reproductive biologist has achieved a major breakthrough in IVF ... around the world who have suffered previous miscarriages after ... Research Fellow and member of the University,s Robinson Institute, ... product which improves IVF embryo implantation rates for some ...
Cached Biology News:Researchers investigate why a limited number of white blood cells are attracted to injured tissue 2Carbon swap bank to beat climate change 2Carbon swap bank to beat climate change 3IVF breakthrough to hit the world market 2
... and Tissue Staining Kits are intended for ... of histological and cytological specimens. These kits ... manufactured by either R&D Systems or by ... the formation of the Avidin-Biotin Complex (ABC) ...
... jetSI-ENDO is an easy-to-use siRNA transfection ... out endogenous genes in a variety of ... comes with an optimized, straightforward protocol. High ... are obtained following transfection of 20 to ...
... jetSI-ENDO-FluoR is a tetramethylrhodamine-conjugated ... emission at 580 nm), the ... reagents are used to determine ... the intracellular delivery and trafficking ...
... in a Morris Water Maze. Tracks up ... sequence of trials.The Spatial Behavior line is a ... camera, frame grabber, and feature extraction software and ... up to 6 moving animals. Software automatically ...
Biology Products: